Bioasis Technologies Inc

(BIOAF)

By |

Profile

Bioasis Technologies Inc is a biopharmaceutical company developing xB3, a proprietary technology for the delivery of therapeutics across the blood-brain barrier and the treatment of CNS disorders, including brain cancers and neurodegenerative diseases.

Contact Information

Website: www.bioasis.us
Email: info@bioasis.us
Main Phone: +1 917 763-2709
Address: 14 Water Street
Address 2: Suite 130
State: CT
City / Town: Guilford
Country: USA
Postal Code: 06437

Issuer Information

Exchange: OTCQB
CEO: Mark Day
NAICS: Pharmaceutical Preparation Manufacturing (325412)
$ 0.39 $ 0.01216 (3.25%)
Last Price 0.39 Change $ 0.01216 Change % 3.25 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open 0.38 High 0.39 Low 0.38 Prev Close 0.37
Last Trade Volume 500 52 Wk Hi 0.94 52 Wk Low 0.34
Market Cap 21.9 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 56,825,250.00 EPS (TTM) -0.07 PE Ratio N/A Exchange OTCQB
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 1.83 1.83 1.83 1.83
Low Target Price Estimate 1.83 1.83 1.83 1.83
Mean Target Price Estimate 1.83 1.83 1.83 1.83
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 04/17/14 04/17/14 04/17/14 04/17/14
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 1